M.D. Sass LLC Lowers Stock Holdings in AMETEK, Inc. $AME

M.D. Sass LLC reduced its position in shares of AMETEK, Inc. (NYSE:AME) by 4.5% in the 1st quarter, HoldingsChannel.com reports. The firm owned 361,795 shares of the technology company’s stock after selling 17,185 shares during the quarter. AMETEK comprises approximately 5.9% of M.D. Sass LLC’s portfolio, making the stock its 3rd biggest holding. M.D. Sass LLC’s holdings in AMETEK were worth $77,554,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Compound Planning Inc. increased its position in AMETEK by 13.0% during the 1st quarter. Compound Planning Inc. now owns 2,526 shares of the technology company’s stock worth $542,000 after buying an additional 290 shares during the period. Volterra Technologies LP bought a new stake in shares of AMETEK in the first quarter valued at about $390,000. Arrowstreet Capital Limited Partnership grew its stake in shares of AMETEK by 22.0% in the first quarter. Arrowstreet Capital Limited Partnership now owns 542,044 shares of the technology company’s stock valued at $116,193,000 after acquiring an additional 97,716 shares in the last quarter. Caxton Associates LLP grew its stake in shares of AMETEK by 12.2% in the first quarter. Caxton Associates LLP now owns 16,622 shares of the technology company’s stock valued at $3,563,000 after acquiring an additional 1,804 shares in the last quarter. Finally, Inceptionr LLC bought a new position in AMETEK during the first quarter worth about $827,000. 87.43% of the stock is currently owned by institutional investors.

AMETEK Price Performance

Shares of NYSE:AME opened at $241.01 on Friday. The firm has a 50 day moving average of $231.62 and a 200-day moving average of $227.40. AMETEK, Inc. has a 12 month low of $175.61 and a 12 month high of $244.71. The company has a current ratio of 1.14, a quick ratio of 0.72 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $55.24 billion, a PE ratio of 36.41, a PEG ratio of 3.32 and a beta of 0.99.

AMETEK (NYSE:AME) last posted its quarterly earnings results on Thursday, April 30th. The technology company reported $1.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.07. AMETEK had a net margin of 20.11% and a return on equity of 16.63%. The business had revenue of $1.93 billion for the quarter, compared to analyst estimates of $1.91 billion. During the same quarter last year, the business posted $1.75 EPS. The firm’s revenue for the quarter was up 11.3% on a year-over-year basis. AMETEK has set its FY 2026 guidance at 7.940-8.140 EPS and its Q2 2026 guidance at 1.960-2.000 EPS. On average, equities research analysts predict that AMETEK, Inc. will post 8.14 EPS for the current fiscal year.

AMETEK Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, June 15th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Monday, June 15th. AMETEK’s dividend payout ratio is currently 20.54%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on AME shares. BMO Capital Markets initiated coverage on shares of AMETEK in a report on Friday, March 27th. They issued an “outperform” rating and a $253.00 price objective for the company. Morgan Stanley lifted their price target on shares of AMETEK from $235.00 to $245.00 and gave the company an “equal weight” rating in a research report on Friday, July 10th. Weiss Ratings upgraded AMETEK from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, June 29th. Mizuho set a $270.00 price target on AMETEK in a research report on Friday, May 1st. Finally, Truist Financial raised their price objective on AMETEK from $275.00 to $303.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $256.29.

AMETEK Profile

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.